Intersection of interferon and hypoxia signal transduction pathways in nitric oxide-induced tumor apoptosis

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3682-3688

  Tendler, Drory S ^a   Bao, Clare ^a   Wang, Tianhong ^a   Huang, Eric L ^b   Ratovitski, Edward A ^a   Pardoll, Drew A ^a   Lowenstein, Charles J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON; INTERFERON REGULATORY FACTOR 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL HYPOXIA; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; INTERFERON PRODUCTION; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; BINDING SITES; CELL HYPOXIA; DNA-BINDING PROTEINS; ENZYME INDUCTION; FEMALE; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; MACROPHAGE ACTIVATION; MACROPHAGES; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; RNA, MESSENGER; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0035328635     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (103)

1. Nitric oxide and macrophage function
2. The central role of CD4(+) T cells in the antitumor immune response
3. The role of CD4+ T cell responses in antitumor immunity
4. The macrophage response to infectious agents: Mechanisms of macrophage activation and turnout cell killing
5. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages
6. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes
7. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme
8. Nitric oxide: A cytotoxic activated macrophage effector molecule
9. Macrophage cytotoxicity: Role for L-arginine deiminase and imino nitrogen oxidation to nitrite
10. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells
11. Nitric oxide and oxygen radicals in infection, inflammation, and cancer
12. Nitric oxide and its role in apoptosis
13. The multifaceted roles of nitric oxide in cancer
14. Inverse correlation between expression of inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells
15. GM-CSF-transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune-compromised mice
16. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells
17. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms
18. Nitric oxide synthesis contributes to IL-2-induced antitumor responses against intraperitoneal Meth A tumor
19. Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets
20. Abrogation of tumorigenicity and metastasis of murine and human tumor cells by transfection with the murine IFN-β gene: Possible role of nitric oxide
21. Destruction of bystander cells by tumor cells transfected with inducible nitric oxide (NO) synthase gene
22. Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362
23. Macrophage nitric oxide synthesis delays progression of ultraviolet light-induced murine skin cancers
24. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide
25. Role of nitric oxide in lysis of tumor cells by cytokine-activated endothelial cells
26. Redox signaling: Nitrosylation and related target interactions of nitric oxide
27. Biochemistry of nitric oxide and its redox-activated forms
28. The concept of type-1 and type-2 helper T cells and their cytokines in humans
29. CD4 T cells and their role in antitumor immune responses
30. Role of interferon regulatory factor 1 in induction of nitric oxide synthase
31. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase
32. Nitric oxide synthases: Roles, tolls, and controls
33. Inducible nitric oxide synthase: What difference does it make?
34. Natural resistance and nitric oxide
35. Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: Initial analysis of the human NOS2 promoter
36. Macrophage nitric oxide synthase gene: Two upstream regions mediate induction by interferon λ and lipopolysaccharide
37. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon y and bacterial lipopolysaccharide
38. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages
39. An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and lipopolysaccharide
40. The role of interferon regulatory factors in the interferon system and cell growth control
41. Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1
42. The growing family of interferon regulatory factors
43. IRF-1 and IRF-2 as regulators of the interferon system and cell growth
44. Recent progress in the elucidation of interferon-γ actions: Molecular biology and biological functions
45. Regulation of interferon-β gene: Structure and function of cis-elements and trans-acting factors
46. Interferon regulatory factors: The next generation
47. Role of the interferon regulatory factors (IRFs) in virus-mediated signaling and regulation of cell growth
48. Transcription factors IRF-1 and IRF-2: Linking the immune responses and tumor suppression
49. Signal transduction and gene control
50. Multiple NF-κB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene
51. Interaction of interferon regulatory factor-1 and nuclear factor κB during activation of inducible nitric oxide synthase transcription
52. Oxygen delivery: Implications for the biology and therapy of solid tumors
53. Measurement of tumor hypoxia by invasive and non-invasive procedures: A review of recent clinical studies
54. Hypoxic fractions of human tumors xenografted into mice: A review
55. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine
56. Regulation of inducible nitric oxide synthase expression in IFN-γ-treated murine macrophages cultured under hypoxic conditions
57. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter
58. Induction of IL-12 and chemokines by hyaluronan requires adhesion- dependent priming of resident but not elicited macrophages
59. An essential role for p300/CBP in the cellular response to hypoxia
60. Purification and cloning of interferon-stimulated gene factor 2 (ISGF2): ISGF2 (IRF-1) can bind to the promoters of both B interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either
61. Recruitment of CBP/p300 by the IFN β enhanceosome is required for synergistic activation of transcription
62. Structure and function of the interferon-β enhanceosome
63. The role of HMG I(Y) in the assembly and function of the IFN-β enhanceosome
64. The enhanceosome and transcriptional synergy
65. Reversal of intrinsic DNA bends in the IFN β gene enhancer by transcription factors and the architectural protein HMG I(Y)
66. Virus induction of human IFN β gene expression requires the assembly of an enhanceosome
67. The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome
68. Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter
69. A classical enhancer element responsive to both lipopolysaccharide and interferon-γ augments induction of the iNOS gene in mouse macrophages
70. Nitric oxide reduces early growth response-1 gene expression in rat lung macrophages treated with interferon-γ and lipopolysaccharide
71. Nitric oxide: A physiologic messenger
72. Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors
73. Molecular mechanisms of transcription activation by HLF and HIF-1α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300
74. Signal transduction in hypoxic cells: Inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α
75. Regulation of transcription by hypoxia requires a multiprotein complex that includes hypoxia-inducible factor 1, an adjacent transcription factor, and p300/CREB binding protein
76. NO: An inhibitor of cell death
77. Fas-induced caspase denitrosylation
78. Nitric oxide inhibits Fas-induced apoptosis
79. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation
80. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation
81. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide
82. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
83. Nitric oxide inhibits apoptosis by preventing increases in caspase-3- like activity via two distinct mechanisms
84. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes
85. Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release
86. Adenovirus-mediated inducible nitric oxide synthase gene transfer inhibits hepatocyte apoptosis
87. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression
88. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: Role of hypoxia responsive element
89. Erythropoietin 5′-flanking sequence-binding protein induced during hypoxia and cobalt exposure
90. Stimulation of erythropoietin gene transcription during hypoxia and cobalt exposure
91. Increased levels of erythmpoietin in kidney extracts of rats treated with cobalt and hypoxia
92. Effects of testosterone, cobalt and hypoxia on erythropoietin production in the isolated perfused dog kidney
93. The influence of hypoxemia and cobalt on erythropoietin production in the isolated perfused dog kidney
94. The lactate dehydrogenase isoenzymes in various organs of the rabbit in anaemia, hypoxia, and after cobalt administration
95. Perspectives on oxygen sensing
96. 2 tension
97. The hypoxic response: Huffing and HIFing
98. 2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
99. Targeting gene expression to hypoxic tumor cells
100. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
101. Expression of hypoxia-inducible factor 1α in brain tumors: Association with angiogenesis, invasion, and progression
102. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
103. Increased expression of hypoxia inducible factor-1α in rat and human prostate cancer